LYRA

Lyra Therapeutics, Inc. Common Stock

2.02

USD

LYRA Earnings Reports

Positive Surprise Ratio

LYRA beat 11 of 23 last estimates.

48%

Next Report

Date of Next Report

Mar 11, 2026

Estimate for Q4 25 (Revenue/ EPS)

$190.74K

-$5.71

Implied change from Q3 25 (Revenue/ EPS)

+662.96%

+68.93%

Implied change from Q4 24 (Revenue/ EPS)

-8.74%

-28.63%

Lyra Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, LYRA reported earnings of -3.38 USD per share (EPS) for Q3 25, beating the estimate of -5.36 USD, resulting in a 36.94% surprise. Revenue reached 25.00 thousand, compared to an expected 198.90 thousand, with a -87.43% difference. The market reacted with a -1.55% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 6 analysts forecast an EPS of -5.71 USD, with revenue projected to reach 190.74 thousand USD, implying an increase of 68.93% EPS, and increase of 662.96% in Revenue from the last quarter.

FAQ

What were Lyra Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Lyra Therapeutics, Inc. Common Stock reported EPS of -$3.38, beating estimates by 36.94%, and revenue of $25.00K, -87.43% below expectations.

How did the market react to Lyra Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -1.55%, changed from $3.88 before the earnings release to $3.82 the day after.

When is Lyra Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 11, 2026.

What are the forecasts for Lyra Therapeutics, Inc. Common Stock's next earnings report?

Based on 6 analysts, Lyra Therapeutics, Inc. Common Stock is expected to report EPS of -$5.71 and revenue of $190.74K for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.